跳至主要内容
临床试验/NL-OMON22123
NL-OMON22123招募中不适用

Hemophilia in the Netherlands-6 study

eiden University Medical Centre0 个研究点目标入组 1,260 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
1,260

研究概览

简要总结

o publications as of yet

研究设计

研究类型
Observational non invasive

入排标准

入选标准

  • Male patients with severe, moderate or mild congenital haemophilia A or B with endogenous clotting factor activity levels <0.40 IU/ml who are registered at one the haemophilia treatment centres in the Netherlands.
  • - Male patients with congenital haemophilia A or B who underwent liver transplantation in the past (irrespective of their endogenous clotting factor levels).
  • - All currently deceased male haemophilia A or B patients that participated in the HiN-5 questionnaire in 2001.
  • - For patients = 16 years old; written informed consent.
  • - For patients 12-15 years old; written informed consent from both the patient and their parents/legal guardian(s).
  • - For patients <12 years old; written informed consent from their parents/legal guardian(s).

排除标准

  • - Female carriers of haemophilia A or B
  • - Patients with acquired haemophilia.
  • - Non-haemophilic patients with reduced FVIII levels due to VWD.

研究者

发起方
eiden University Medical Centre

相似试验